These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 12629979

  • 1. Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.
    Kim YT, Byun JS, Kim J, Jang YH, Lee WJ, Ryu JK, Kim SW, Yoon YB, Kim CY.
    Hepatogastroenterology; 2003; 50(49):8-12. PubMed ID: 12629979
    [Abstract] [Full Text] [Related]

  • 2. Hepatolithiasis associated with cholangiocarcinoma.
    Kubo S, Kinoshita H, Hirohashi K, Hamba H.
    World J Surg; 1995; 19(4):637-41. PubMed ID: 7676713
    [Abstract] [Full Text] [Related]

  • 3. [Hepatolithiasis simulating a cholangiocarcinoma].
    Vergara Suárez F, López Andújar R, Montalvá Orón E, Ramírez Ribelles C, Pérez Rojas J.
    Cir Esp; 2013 Oct; 91(8):535-7. PubMed ID: 23911084
    [No Abstract] [Full Text] [Related]

  • 4. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.
    Lesurtel M, Regimbeau JM, Farges O, Colombat M, Sauvanet A, Belghiti J.
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1025-7. PubMed ID: 12352225
    [Abstract] [Full Text] [Related]

  • 5. Late development of cholangiocarcinoma after the treatment of hepatolithiasis.
    Chijiiwa K, Ichimiya H, Kuroki S, Koga A, Nakayama F.
    Surg Gynecol Obstet; 1993 Sep; 177(3):279-82. PubMed ID: 8395085
    [Abstract] [Full Text] [Related]

  • 6. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA.
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [Abstract] [Full Text] [Related]

  • 7. Cholangiocarcinoma Risk as Long-term Outcome After Hepatic Resection in the Hepatolithiasis Patients.
    Kim HJ, Kim JS, Suh SJ, Lee BJ, Park JJ, Lee HS, Kim CD, Bak YT.
    World J Surg; 2015 Jun; 39(6):1537-42. PubMed ID: 25648078
    [Abstract] [Full Text] [Related]

  • 8. Characteristic Features of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis.
    Ishii Y, Sasaki T, Serikawa M, Kobayashi K, Kamigaki M, Minami T, Okazaki A, Yukutake M, Ishigaki T, Kosaka K, Mouri T, Yoshimi S, Chayama K.
    Hepatogastroenterology; 2014 May; 61(131):567-73. PubMed ID: 26176037
    [Abstract] [Full Text] [Related]

  • 9. Malignancy associated with hepatolithiasis.
    Chu KM, Lo CM, Liu CL, Fan ST.
    Hepatogastroenterology; 1997 May; 44(14):352-7. PubMed ID: 9164501
    [Abstract] [Full Text] [Related]

  • 10. Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study.
    Lumachi F, Lo Re G, Tozzoli R, D'Aurizio F, Facomer F, Chiara GB, Basso SM.
    Anticancer Res; 2014 Nov; 34(11):6663-7. PubMed ID: 25368272
    [Abstract] [Full Text] [Related]

  • 11. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma--the influence of sampling time and hepatolithiasis.
    Chen CY, Shiesh SC, Tsao HC, Lin XZ.
    Hepatogastroenterology; 2002 Nov; 49(45):616-20. PubMed ID: 12063953
    [Abstract] [Full Text] [Related]

  • 12. Hepatolithiasis associated with cholangiocarcinoma. Possible etiologic significance.
    Koga A, Ichimiya H, Yamaguchi K, Miyazaki K, Nakayama F.
    Cancer; 1985 Jun 15; 55(12):2826-9. PubMed ID: 2986827
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and surgical treatment of intrahepatic hepatolithiasis associated cholangiocarcinoma.
    Han SL, Zhou HZ, Cheng J, Lan SH, Zhang PC, Chen ZJ, Zeng QQ.
    Asian J Surg; 2009 Jan 15; 32(1):1-6. PubMed ID: 19321395
    [Abstract] [Full Text] [Related]

  • 14. Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures.
    Lempinen M, Isoniemi H, Mäkisalo H, Nordin A, Halme L, Arola J, Höckerstedt K, Stenman UH.
    J Hepatol; 2007 Nov 15; 47(5):677-83. PubMed ID: 17640760
    [Abstract] [Full Text] [Related]

  • 15. Segmental cholangiectasia clinically worrisome for cholangiocarcinoma: comparison with recurrent pyogenic cholangitis.
    Zhao L, Hosseini M, Wilcox R, Liu Q, Crook T, Taxy JB, Ferrell L, Hart J.
    Hum Pathol; 2015 Mar 15; 46(3):426-33. PubMed ID: 25600951
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors of hepatolithasis-associated intrahepatic cholangiocarcinoma and the value of serum tumor-related makers in its diagnosis].
    Yang C, Zhang J, Lin YX, Zhou RX, Xiong XZ, Cheng NS.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul 15; 45(4):628-32. PubMed ID: 25286689
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of sarcopenia combined with hepatolithiasis in intrahepatic cholangiocarcinoma patients after surgery: A prospective cohort study.
    Deng L, Wang Y, Zhao J, Tong Y, Zhang S, Jin C, Chen K, Bao W, Yu Z, Chen G.
    Eur J Surg Oncol; 2021 Mar 15; 47(3 Pt B):603-612. PubMed ID: 32933804
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic cholangiocarcinoma in hepatolithiasis: A frequently overlooked disease.
    Sheen-Chen SM, Chou FF, Eng HL.
    J Surg Oncol; 1991 Jun 15; 47(2):131-5. PubMed ID: 1648151
    [Abstract] [Full Text] [Related]

  • 19. What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?
    Lee CC, Wu CY, Chen GH.
    J Gastroenterol Hepatol; 2002 Sep 15; 17(9):1015-20. PubMed ID: 12167124
    [Abstract] [Full Text] [Related]

  • 20. Hepatolithiasis associated with cholangiocarcinoma.
    Su CH, Shyr YM, Lui WY, P'Eng FK.
    Br J Surg; 1997 Jul 15; 84(7):969-73. PubMed ID: 9240138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.